SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending ahead of its quarterly earnings report, with the community actively debating whether the stock's recent volatility and mixed options flow signal a significant post-earnings breakout or a potential sell-off. Investors remain focused on the company's long-term growth initiatives, including international expansion and its evolving role in prediction markets, despite current debates over the stock's sensitivity to broader crypto market trends and analyst revisions.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trading with heightened volatility as investors weigh strong underlying revenue growth and record member additions against a bearish flow of put activity ahead of earnings. Community discourse remains deeply divided between long-term bulls highlighting the company's ecosystem expansion and bears focusing on historical sell-offs, dilution concerns, and macro-driven price suppression.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is surging as investors cheer a massive contract expansion with Oracle to power its rapidly growing AI data center infrastructure, effectively positioning the company as a critical solution to the sector's power bottlenecks. Community sentiment remains aggressively bullish, with traders buzzing about the stock's parabolic momentum and its emerging role as essential infrastructure for the AI revolution.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to the announcement of a definitive agreement to acquire European Lithium in a deal valued at approximately 835 million dollars, which aims to consolidate full ownership of the Tanbreez rare earth project and simplify the company's capital structure. Community sentiment is largely bullish, with investors actively discussing the potential for a massive short squeeze due to high borrowing fees, while also monitoring for upcoming project updates and potential government support.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is generating significant debate among traders as they navigate technical resistance levels ahead of upcoming earnings, with the community closely tracking the stock's role in the evolving energy independence narrative. Discussions remain split between those anticipating a volatile post-earnings breakout driven by data center demand and VPP innovation, and those maintaining caution due to persistent macro-economic headwinds and sector-wide sentiment swings.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology is trending following a significant earnings beat and robust guidance that underscores the massive, persistent demand for AI-driven data storage and cloud infrastructure. The community is actively debating whether the stock's parabolic climb represents a sustainable re-rating or a vulnerable bubble, as investors weigh high valuation multiples against the long-term reality of a constrained supply environment.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is trending ahead of its quarterly earnings release as investors scrutinize whether CEO Brian Niccol's "Back to Starbucks" turnaround plan is successfully driving traffic and margin recovery. The community remains divided, with some traders debating potential short-term volatility while others closely watch for signs of operational improvement amidst broader consumer spending headwinds.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing high engagement following full FCC commercial approval for its 248-satellite constellation, a major regulatory milestone that investors view as a key de-risking event. Despite this, the stock faces downward pressure from institutional share liquidations and community debate regarding launch cadences, with traders actively monitoring support levels as they weigh long-term partnership potential against short-term volatility.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is currently trending following successful point-to-point test flights in New York City and ongoing FAA certification progress, fueling intense community debate regarding its long-term commercial viability. While bulls point to strong institutional backing and technical milestones, bears are focused on volatility, cash burn concerns, and competitive pressure in the crowded air taxi sector.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is trending following an earnings report that showcased robust revenue and EPS growth, with the community actively debating whether current price action represents a buying opportunity or a reaction to broader regulatory uncertainties. Investors remain focused on the company's resilient transaction volumes and global payment network dominance, even as broader market discussions weigh the potential impact of fintech disruption and shifts in consumer spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The study will evaluate the drug’s safety, effectiveness, and tolerability, with initiation expected in the second quarter of 2026.</li><li>Lucid-MS is designed to protect nerves by targeting Demyelination, a key factor for multiple sclerosis progression.</li><li>Allucent will provide end-to-end support for the clinical trial, including execution and data management.</li></ul>Shares of Quantum BioPharma (QNTM) surged 15% in pre-market trading on Monday after the biotech firm signed a binding agreement with Allucent to support a planned Phase 2 trial of its Lucid-MS therapy for multiple sclerosis.The study will evaluate the drug’s safety, effectiveness, and tolerability, with initiation expected in the second quarter of 2026, Quantum BioPharma said.Lucid-MS is designed to protect nerves by targeting Demyelination, a key factor for multiple sclerosis progression. Allucent will provide end-to-end support for the clinical trial, including execution and data management.“This innovative mechanism represents a differentiated therapeutic approach in the global MS market where an estimated 2.8 million people suffer and where many existing treatments primarily focus on modulating the immune system rather than addressing the underlying neurodegeneration,” said Andrzej Chruscinski, VP, Scientific and Clinical Affairs at Quantum BioPharma.&nbsp;&nbsp;<h2 class="st-heading-2">Funding Update</h2>Earlier this month, Quantum BioPharma completed oral dosing of Lucid-21-302 (Lucid-MS) in both its 180-day toxicity and toxicokinetic studies, marking an important step toward filing an Investigational New Drug (IND) application with the U.S. FDA. The company is focused on developing innovative treatments for neurodegenerative, metabolic, and alcohol-related disorders, with multiple drug candidates in its pipeline.Alongside clinical progress, Quantum BioPharma also strengthened its financial position by closing the first tranche of a previously announced offering, raising $3.75 million through the issuance of 3,750 debenture units.&nbsp;Additionally, the company settled about $1.12 million in debt by issuing over 370,000 Class B shares to certain creditors and insiders, helping improve its balance sheet.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/QNTM">QNTM</a> remained 'bullish' over the past 24 hours, amid 'extremely high' message volumes.One user said the company's market cap should be "north of $100 million" following the developments.<stembedurl>https://stocktwits.com/TAGtrade/message/648919385</stembedurl>Year-to-date, the stock has declined 30%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart can be seen in a trading platform on a smartphone. Top U.S. firms announced record buybacks this year. (Photo by Silas Stein/picture alliance via Getty Images)

Why Did QNTM Stock Pop In Pre-Market Today?

The biotech company signed a binding agreement with Allucent to support a planned Phase 2 trial to treat multiple sclerosis.

Equity

Quantum BioPharma Targets MS Progression with Novel Demyelination Therapy in Phase 2 Push

Quantum BioPharma (NASDAQ:QNTM) is taking a meaningful step forward in its clinical ambitions, signing a binding letter of intent with Allucent to advance its lead multiple sclerosis candidate, Lucid-21-302 (Lucid-MS), into a Phase 2 trial. The agreement signals more than operational progress, it reflects a broader push to bring differentiated, next-generation therapies into a market that remains heavily underserved despite decades of innovation.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM INVESTOR ALERT: Pomerantz Law Firm...

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM CONTACT: INVESTOR ALERT...

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to...

<ul class="summary-bullets"><li>The stock surged as Canadian media spotlight renewed scrutiny of Quantum’s alleged market-spoofing case.</li><li>The coverage drew fresh attention to the company’s $700 million federal lawsuit over price manipulation.</li><li>Lucid-MS’s Phase 1 safety data in August supported advancement toward patient trials.</li></ul>Quantum BioPharma shares surged on Tuesday after a Canadian media investigation spotlighted the company’s claims that years of alleged stock spoofing depressed its valuation and harmed its lead multiple-sclerosis program. The renewed attention came as CTV’s investigative flagship W5 began airing a three-part series examining Quantum’s lawsuit seeking more than $700 million in damages.The stock closed up 30% at $8.04 on Tuesday and added another 5% in after-hours trading.<h2 class="st-heading-2">CTV Investigation Highlights Company’s Manipulation Claims</h2>The W5 series focuses on Quantum’s allegation that its shares were repeatedly manipulated through illegal “stock spoofing” conducted by CIBC World Markets, RBC Dominion Securities and others from January 2020 to August 2024. The practice, which involves placing and canceling non-bona fide buy and sell orders, is prohibited in both Canada and the U.S.W5 reporter Jon Woodward previewed the first installment in an article titled “Was a Canadian company’s multiple sclerosis research nearly derailed by ‘market manipulation’?” The program began airing Part One on Tuesday, drawing renewed attention to Quantum’s claims and its ongoing legal fight.<h2 class="st-heading-2">Quantum Alleges Banks Used Spoofing To Drive Shares Lower</h2>Quantum filed its initial complaint in October 2024 in the U.S. District Court for the Southern District of New York and amended it in May after defendants moved to dismiss. The company alleges violations of the Securities Exchange Act, asserting that hundreds of spoofing events artificially pushed its stock lower.Quantum said its shares traded above $460 on a split-adjusted basis in early 2020 with a market cap near $1 billion, compared with $7.55 by October 2024. The firm also maintains that additional banks or brokers may have been involved, but said it will not identify them until it has gathered sufficient evidence.The law firms Christian Attar and Freedman Normand Friedland LLP are pursuing the case on a contingency basis after conducting an extensive investigation with industry experts.<h2 class="st-heading-2">Progress In Lucid-MS Program&nbsp;</h2>In August, Quantum BioPharma reported that its lead multiple sclerosis candidate, Lucid-MS, passed a key safety hurdle after a Phase 1 multiple-ascending-dose study found no safety or tolerability issues in healthy volunteers. The company said the clinical study report supported its plans to advance into patient efficacy trials.Lucid-MS is a first-in-class, non-immunomodulatory neuroprotective compound designed to prevent or reverse myelin degradation, based on preclinical data.&nbsp;<h2 class="st-heading-2">Stocktwits Users Eye A Sharp Rebound</h2>On Stocktwits, retail sentiment for Quantum BioPharma was ‘extremely bullish’ amid a 3,400% surge in 24-hour message volume.<figure class="image"><img style="aspect-ratio:971/141;" src="https://news.stocktwits-cdn.com/qntm_ss_png_e73bb7bac7.webp" alt="qntm ss.png" width="971" height="141"><figcaption>QNTM sentiment and message volume as of November 26 | Source: Stocktwits</figcaption></figure>One user predicted, “shorts will be covering tomorrow due to thanksgiving. Should see $18 soon.”<stembedurl>https://stocktwits.com/James9921/message/637453956</stembedurl>Another user said, “this one has been absolutely wrecked here but historically when the stocks this low it sees a violent move up. Watching closely here.”<stembedurl>https://stocktwits.com/makedatbread88/message/637220177</stembedurl><a href="https://stocktwits.com/symbol/QNTM">Quantum BioPharma’s stock</a> has more than doubled so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Quantum BioPharma’s stock (QNTM) has more than doubled so far in 2025. (Photo credit: Getty Images)

Quantum BioPharma Stock Rockets As Media Probe Shines Light On Spoofing Allegations Linked To Its $700M Lawsuit

Lucid-MS’s Phase 1 safety data in August supported advancement toward patient trials.

Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights QNTM

The DJS Law Group announces that it is investigating claims on behalf of investors of Quantum BioPharma Ltd. (Quantum BioPharma or the Company) (NASDAQ: QNTM) for violations of the securities laws...

Quantum BioPharma Ltd. is a biopharmaceutical company, which engages in building a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory, metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. It operates through the Biopharmaceutical and Strategic Investments segments. The Biopharmaceutical segment focuses on furthering the research and development of the drug candidates and the development of a treatment for alcohol misuse for application in hospitals and other medical practices. The Strategic Investments segment is involved in the generation of returns and cash flow through the issuance of loans secured by residential property, with FSD Strategic Investments having a first or second collateral mortgage on the secured property. The company was founded by Thomas Fairfull, Zeeshan Saeed, and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)

Hold rates steady

Cut 25 bps

Hike 25 bps

What do you expect the Fed to decide at its FOMC meeting Wednesday?

Stocktwits

Stocktwits Polls

Quantum BioPharma Ltd

Technical analysis highlights key breakout zones near $5 with traders eyeing momentum indicators like MACD and ADX for trend confirmation.

QNTM
Quantum BioPharma Ltd

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest QNTM News

QNTMQuantum BioPharma Ltd